Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/content/pdf/10.1007/s10549-010-1216-1.pdf
Reference51 articles.
1. American Cancer Society (2009) Breast cancer facts and figures 2009–2010. ACS, Atlanta
2. Earle CC, Nattinger AB, Potosky AL et al (2002) Identifying cancer relapse using SEER-Medicare Data. Med Care 40(8 Suppl):IV-75–81
3. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365:1687–1717
4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (1998) Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352:930–942
5. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) (1992) Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer: an overview of 61 randomised trials among 28,896 women. N Engl J Med 319:1681–1692
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chemotherapy-Induced Toxicities and Their Associations with Clinical and Non-Clinical Factors among Breast Cancer Patients in Vietnam;CURR ONCOL;2022
2. Chemotherapy-Induced Toxicities and Their Associations with Clinical and Non-Clinical Factors among Breast Cancer Patients in Vietnam;Current Oncology;2022-10-31
3. Impact of a G-CSF Policy to Reduce Low-Value Care on Guideline Adherence and Mortality;JCO Oncology Practice;2021-11
4. Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy;American Journal of Clinical Oncology;2017-02
5. Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update;Journal of Clinical Oncology;2015-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3